Abbott sues to block sales of drug in generic form before patents expire

    By
    BizTimes Staff
    -

    Abbott Laboratories has sued to prevent Watson Pharmaceuticals Inc. from commercializing a generic version of the cholesterol drug Niaspan before the drug’s patents expire.

    Read more.

    RELATED ARTICLES

    Copyright ©2024 BizTimes Media, LLC. All Rights Reserved.

    Abbott Laboratories has sued to prevent Watson Pharmaceuticals Inc. from commercializing a generic version of the cholesterol drug Niaspan before the drug's patents expire.

    Read more.

    Holiday flash sale!

    Limited time offer. New subscribers only.

    Subscribe to BizTimes Milwaukee and save 40%

    Holiday flash sale! Subscribe to BizTimes and save 40%!

    Limited time offer. New subscribers only.

    Exit mobile version